Insider Transactions in Q3 2021 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
4,000
+0.94%
|
$24,000
$6.02 P/Share
|
|
Aug 05
2021
|
Wendy Guy Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,036
-1.08%
|
$16,144
$4.69 P/Share
|
|
Aug 05
2021
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+1.95%
|
-
|
|
Aug 05
2021
|
Virgil Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+8.68%
|
-
|
|
Aug 05
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+1.78%
|
-
|
|
Aug 05
2021
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+14.7%
|
-
|
|
Aug 05
2021
|
Sian Bigora Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+1.89%
|
-
|
|
Aug 05
2021
|
Wendy Guy Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+3.96%
|
-
|
|
Aug 05
2021
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+0.39%
|
-
|
|
Aug 05
2021
|
Geraldine Pannu |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+17.0%
|
-
|